Inhibitory Effects of Kampo Medicine on Human UGT2B7 Activity
Inhibitory Effects of Kampo Medicine on Human UGT2B7 Activity
复制标题
DOI:
10.2133/dmpk.24.490
复制
发表时间:
2009-01-01
影响因子:
2.1
通讯作者:
Yokoi, Tsuyoshi
中科院分区:
文献类型:
--
作者:
Nakagawa, Nao;Katoh, Miki;Yokoi, Tsuyoshi
Kampo medicine is traditional Japanese medicine modified from the Chinese original. Kampo medicine is a mixture of several medicinal herbs and includes many ingredients such as glycosides. Glycosides are hydrolyzed to aglycons by intestinal bacterial flora and absorbed into the body. Aglycons such as baicalein and glycyrrhetinic acid can be conjugated by UDP-glucuronosyltransferase (UGT) in human liver or small intestine. UGT2B7 is one of the major isoforms responsible for drug conjugation including morphine 3- and 3'-azido-3'-deoxythymidine (AZT) glucuronidation. The present study investigates the effects of 51 Kampo medicines, 14 medicinal herbs and 11 ingredients on UGT2B7 activity in human liver microsomes. Morphine 3-glucuronidation was inhibited by more than 50% by 9 of 51 Kampo medicines such as Ryo-kei-jutsu-kan-to. AZT glucuronidation was inhibited by more than 50% by 24 of 51 Kampo medicines such as Jumihaidoku-to. Medicinal herbs such as Daio (Rhei Rhizoma), Kanzo (Glycyrrhizae Radix) and Keihi (Cinnamomi Cortex) exhibited more than 80% inhibition on both glucuronidations. The major ingredients of these medicinal herbs inhibited UGT2B7 activity with low K-i. Kampo medicines were found to inhibit the UGT2B7 activity and may cause drug interactions via the inhibition of UGT.